Antimetabolites Flashcards
Classes of antimetabolites
- Folic acid analogs
- Pyrimidine analogs
- Purine analogs
Drug in folic acid analog class
Methotrexate –> dihydrofolate reductase inhibitor
Methotrexate mechanisms
Dihydrofolate reductase inhibition –> no THF for DNA/RNA synthesis
Polyglutamation traps drug inside cell
Rescue drug given with methotrexate
Leucovorin –> folinic acid, acts as a folate cofactor, allows for some purine/pyrimidine synthesis
Prevents bone-marrow toxicity
Unique mechanism of methotrexate resistance
Decrease in polyglutamation so drug is excreted through ABC transporters
Unique toxicities of methotrexate
GI toxicity and renal precipitation
Drugs that cannot be administered with methotrexate
NSAIDs and probenecid –> reduce renal clearance and increase toxicity
Drugs in pyrimidine analogs class
- 5-fluorouracil (5-FU)
- Capecitabine
- Gemcitabine
- Cytarabine
Mechanism of 5-FU
Inhibits thymidylate synthase –> cells die from lack of thymidine
***Requires metabolic activation to 5-FdUMP to inhibit
Unique toxicities of 5-FU
Hand-foot syndrome
Action of leucovorin given with 5-FU
Leucovorin drives thymidylate synthase to incorporate 5-FU into DNA (acts to enhance activity of 5-FU against thymidylate synthase)
Capecitabine
Oral pro-drug of 5-FU
Hand-foot syndrome appears more frequently
Mechanism of cytarabine
Converted to arabinose-CTP –> Resistance
Inhibits chain elongation
S phase specificity
Unique toxicities of cytarabine
Severe myelosuppression, Stomatitis, elevated hepatic enzymes, pulmonary edema
Gemcitabine mechanism
Deoxycytidine analog converted to triphosphate intracellularly
Results in chain termination
Unique toxicities of gemcitibine
Interstitial pneumonitis –> treat with steroids
Drugs in purine analogs class
- 6-mercaptopurine
- Thioguanine
- Fludarabine
6-mercaptopurine and thioguanine mechanism
Activated by HGPRTase to toxic nucleotides that inhibit enzymes in purine metabolism
What should be done before giving 6-mercaptopurine and thioguanine?
Genotyping for SNPs in TPMT to prevent extreme toxicity due to variable metabolism
Unique mechanism of resistance to mercaptopurine and thioguanine
Decrease or complete lack of HGPRT enzyme to prevent metabolic activation
Dose-limiting toxicity of mercaptopurine or thioguanine
Bone marrow suppression
Hydroxyurea mechanism
Free radical scavenger in catalytic center of ribonucleotide reductase –> prevents formation of deoxyribonucleotides
Unique toxicities for hydroxyurea
Desquamative interstitial pneumonitis, skin toxicities (darkening of the skin)
How does Hand Foot Syndrome occur? What are the symptoms?
Anticancer drugs escape from the capillaries in the hands and feet; erythema, swelling, and pain to the effected areas